Envestnet Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.47M Sell
136,667
-4,284
-3% -$154K ﹤0.01% 2545
2026
Q1
$4.98M Sell
140,951
-2,675
-2% -$109K ﹤0.01% 2315
2025
Q4
$5.83M Sell
143,626
-24,754
-15% -$1.08M ﹤0.01% 2072
2025
Q3
$7.92M Buy
168,380
+40,697
+32% +$2.11M ﹤0.01% 1923
2025
Q2
$6.65M Sell
127,683
-32,067
-20% -$1.76M ﹤0.01% 2008
2025
Q1
$9.65M Buy
159,750
+10,040
+7% +$647K ﹤0.01% 1687
2024
Q4
$10.2M Sell
149,710
-2,015
-1% -$140K ﹤0.01% 1626
2024
Q3
$10.9M Buy
151,725
+11,581
+8% +$817K ﹤0.01% 1570
2024
Q2
$9.71M Buy
140,144
+9,473
+7% +$691K ﹤0.01% 1585
2024
Q1
$10.5M Sell
130,671
-8,159
-6% -$727K ﹤0.01% 1504
2023
Q4
$15.2M Buy
138,830
+3,981
+3% +$412K 0.01% 1187
2023
Q3
$13.6M Buy
134,849
+59,546
+79% +$6.84M 0.01% 1194
2023
Q2
$10.2M Sell
75,303
-2,491
-3% -$304K ﹤0.01% 1287
2023
Q1
$8.08M Buy
77,794
+8,772
+13% +$848K ﹤0.01% 1361
2022
Q4
$6.12M Sell
69,022
-5,463
-7% -$453K ﹤0.01% 1484
2022
Q3
$5.97M Buy
74,485
+10,310
+16% +$973K ﹤0.01% 1433
2022
Q2
$6.14M Buy
64,175
+3,844
+6% +$461K ﹤0.01% 1410
2022
Q1
$8.96M Buy
60,331
+3,753
+7% +$524K ﹤0.01% 1273
2021
Q4
$8.02M Buy
56,578
+6,876
+14% +$974K ﹤0.01% 1314
2021
Q3
$6.5M Buy
49,702
+9,696
+24% +$1.27M ﹤0.01% 1377
2021
Q2
$5.5M Buy
40,006
+242
+0.6% +$33.1K ﹤0.01% 1450
2021
Q1
$5.19M Buy
39,764
+5,912
+17% +$712K ﹤0.01% 1397
2020
Q4
$3.79M Buy
33,852
+3,099
+10% +$293K ﹤0.01% 1403
2020
Q3
$2.42M Sell
30,753
-535
-2% -$43.6K ﹤0.01% 1509
2020
Q2
$2.25M Buy
31,288
+4,625
+17% +$322K ﹤0.01% 1504
2020
Q1
$1.53M Sell
26,663
-4,640
-15% -$428K ﹤0.01% 1561
2019
Q4
$3.5M Buy
31,303
+1,414
+5% +$151K ﹤0.01% 1316
2019
Q3
$2.87M Buy
29,889
+815
+3% +$76.5K ﹤0.01% 1346
2019
Q2
$2.49M Buy
29,074
+12,919
+80% +$1.06M ﹤0.01% 1432
2019
Q1
$1.34M Sell
16,155
-4,644
-22% -$337K ﹤0.01% 1704
2018
Q4
$1.33M Buy
+20,799
New +$1.42M ﹤0.01% 1557
2018
Q3
Sell
-236
Closed -$17K 1493
2018
Q2
$17K Buy
236
+5
+2% +$340 ﹤0.01% 2450
2018
Q1
$15K Sell
231
-15
-6% -$896 ﹤0.01% 2427
2017
Q4
$13K Hold
246
﹤0.01% 2584
2017
Q3
$12K Sell
246
-824
-77% -$41.4K ﹤0.01% 2559
2017
Q2
$54K Hold
1,070
﹤0.01% 2329
2017
Q1
$47K Sell
1,070
-459
-30% -$19.7K ﹤0.01% 2435
2016
Q4
$67K Sell
1,529
-5,663
-79% -$241K ﹤0.01% 2339
2016
Q3
$288K Sell
7,192
-6,232
-46% -$265K ﹤0.01% 1858
2016
Q2
$641K Sell
13,424
-240
-2% -$10.2K ﹤0.01% 1535
2016
Q1
$573K Buy
13,664
+2,600
+23% +$102K ﹤0.01% 1577
2015
Q4
$487K Buy
11,064
+434
+4% +$18.8K ﹤0.01% 1601
2015
Q3
$507K Sell
10,630
-85
-0.8% -$4.67K ﹤0.01% 1592
2015
Q2
$624K Sell
10,715
-1,014
-9% -$54.7K ﹤0.01% 1619
2015
Q1
$592K Buy
+11,729
New +$575K ﹤0.01% 1497
2014
Q4
Sell
-1,795
Closed -$66K 2528
2014
Q3
$66K Buy
1,795
+120
+7% +$4.76K ﹤0.01% 1421
2014
Q2
$74K Buy
1,675
+4
+0.2% +$181 ﹤0.01% 1307
2014
Q1
$73K Sell
1,671
-327
-16% -$14.6K ﹤0.01% 1240
2013
Q4
$85K Buy
1,998
+76
+4% +$2.89K ﹤0.01% 1068
2013
Q3
$65K Buy
1,922
+84
+5% +$2.74K ﹤0.01% 1124
2013
Q2
$57K Buy
+1,838
New +$59.6K ﹤0.01% 1139

Other funds holding CNMD

Envestnet Asset Management's CNMD Position: Q2 2026 in Review

Envestnet Asset Management reduced its CONMED (CNMD) stake by 3% in Q2 2026, selling an estimated $154K and leaving 136,667 shares worth $4.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2545.

Envestnet Asset Management first reported a position in CNMD in Q2 2013 and has held it in 51 quarters since. The position peaked at $15.2M in Q4 2023. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Envestnet Asset Management held 136,667 shares of CONMED worth $4.47M as of Q2 2026.
  • Envestnet Asset Management sold 4,284 CONMED shares in Q2 2026, an estimated $154K.
  • CONMED made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2545 holding.
  • Envestnet Asset Management first reported a position in CONMED in Q2 2013 and has held it in 51 quarters since.
  • Envestnet Asset Management's CONMED position peaked at $15.2M in Q4 2023.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.